Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Argument against low price being forced by PTSC -- divy vs. buy back
Reply New Message
Back To Forum List View

RE: Argument against low price being forced by PTSC -- divy vs. buy back

posted on Jun 23, 2006 07:32AM
I agree, institutional money is key for really making the share price take-off. I have mixed feelings about future divis - I think I`m leaning away from them at the moment.

One of the most unattractive characteristics of this stock is it`s float. Will the buy back decrease the float? If yes, let`s get rid of all float that we can. I hate to sound like a broken record but at .80 or .90 per share, we could easily put a nice dent in the float if a lot of settlements are due in. JMO GLTA

Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply